Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

TCA IR 40

Aliases
Kenacort-A 40, Kenalog®-40, Kenalog®-40 Injection, TCA IR 40 mg (1 other aliases)
Name
Pro-C-Dure 6 Kit
INN Name
kenalog
FDA Approved
Yes

5 clinical trials

2 organizations

2 indications

2 documents

Indication
Osteoarthritis of the Knee
Indication
Type 2 Diabetes Mellitus
Clinical trial
An Open-label, Single Administration Study to Characterize the Systemic Pharmacokinetics and Local Extent and Duration of Exposure of Triamcinolone Acetonide From FX006 in Patients With Osteoarthritis of the Knee
Status: Completed, Estimated PCD: 2016-09-01
Clinical trial
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus
Status: Completed, Estimated PCD: 2016-10-01
Clinical trial
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Status: Completed, Estimated PCD: 2016-01-01
Clinical trial
A Double-Blind, Randomized, Parallel Group, Active Comparator Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects (HPA Axis) of FX006 in Patients With Osteoarthritis of the Knee
Status: Completed, Estimated PCD: 2012-11-01
Clinical trial
An Open-label, Single Administration Study to Characterize the Local Duration of Exposure of Triamcinolone Acetonide From FX006 in Patients With Osteoarthritis (OA) of the Knee
Status: Completed, Estimated PCD: 2014-04-01
Document
DailyMed Label: Pro-C-Dure 5 Kit
Organization
Oaklock, LLC
Document
DailyMed Label: Pro-C-Dure 6 Kit
Organization
Asclemed USA, Inc.